LAB

0.60102.07%
ME

Michael Egholm

President, CEO & Director

Dr. Michael Egholm, Ph.D. served as the President of Biopharmaceuticals and Senior Vice President at Pall Corporation since July 2014 until January 17, 2017. He serves as Director at Abbratech, Inc. and AbbraTech Holdings LLC. He is President, Chief Executive Officer and Director of Standard BioTools Inc. from April 5, 2022. Dr. Egholm previously served as Chief Executive Officer of Standard BioTools, LLC after leaving Danaher Corporation, a global science and technology company, in September 2021. He previously served as the Chief Technology Officer of Danaher Life Sciences, the life sciences arm of Danaher Corporation, from 2017 to September 2021. He served as the Chief Technology Officer of Pall Corporation since June 2010 until 2014. Dr. Egholm has proven leadership in developing and commercializing innovative technologies. He served as Chief Technology Officer and Vice President of Research & Development at 454 Life Sciences Corporation, a center of excellence at Roche Applied Science. At Roche, he spearHeaded several large high-profile programs including the Neanderthal Sequencing project and the sequencing of the first individual human genome. Previously, Dr. Egholm held senior R&D positions with Molecular Staging, where he led commercialization of genome amplification technology and at Applied Biosystems, where he managed market development. He has published well over one hundred papers including several in the prestigious journals Science, Nature and The New England Journal of Medicine. An elected Member of the Royal Danish Academy of Sciences and Letters, Dr. Egholm is the named inventor of 40 U.S. patents. Dr. Egholm had also served as a Member of the Board of Directors of IsoPlexis Corporation, a publicly traded biopharmaceutical company, since 2018 until August 22, 2022. As a research associate at the University of Copenhagen, Dr. Egholm was the lead inventor of peptide nucleic acids (PNA) technology, a synthetic form of DNA, for which he earned his Ph.D. in organic chemistry. Dr. Egholm earned a Ph.D. and Master’s degree in Chemistry from the University of Copenhagen.

公司职务